A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
Clinical trial NCT06174766 · COMPLETED
Trial details
- NCT number
- NCT06174766
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-10
- Primary completion
- 2026-01-08
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.